Clinical Trials / Research Studies
Common Variable Immunodeficiency With Interstitial Lung Disease Study for Children and Adults
Why are we doing this research?
Cincinnati Children's is conducting a research study, sometimes known as a clinical trial or clinical study, to test the drug abatacept to see what effects is has on interstitial lung disease in patients with common variable immunodeficiency, looking at its impact, safety and tolerability.Who can participate?
Children at least 4 years old and adults with interstitial lung disease with common variable immunodeficiency may be eligible to participate.
Conditions
- Immune Deficiency and Histiocytosis
- Allergy
Gender
- Female
- Male
What will happen in the study?
The study includes 13 study visits (8 over the phone and 5 clinic visits) over 52 weeks. Visits will be approximately every 3 months, and there will be phone calls in between scheduled visits.
Participants will:
- Receive the study drug as an injection under the skin once per week at the dose determined by the study doctor. Adults in the study or parents will administer the injection at home between scheduled study visits. We will train you how to give the injection.
- Have monthly blood draws.
- Be contacted by phone once a month to see how you or your child is feeling, and to answer related questions and complete questionnaires
You will be given a consent form that thoroughly explains all of the details of the study. A member of the study staff will review the consent form with you and will be sure that all of your questions are answered prior to the start of the study.
What are the good things that can happen from this research?
We cannot promise any benefits to you or your child from your taking part in this study. However, you or your child could see symptom improvement while taking the active study drug. Overall, the results from the study may help children and adults with interstitial lung disease with common variable immunodeficiency in the future.What are the bad things that can happen from this research?
We will discuss possible risks and discomforts with you prior to the start of the study. Some common side effects include headache, upper respiratory tract infection, nausea or a simple cold.Will you/your child be paid to be in this research study?
There is no payment for being part of this study.Contact
Study Coordinator513-803-5446
ABCVILD@cchmc.org
Cincinnati Children’s Hospital Medical Center
3333 Burnet Ave.
Cincinnati, OH 45229-3039
Study Doctor
Erinn Kellner, MDMichael Jordan, MD
Allergy and Immunology
Cincinnati Children’s Hospital Medical Center
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2024 Cincinnati Children's Hospital Medical Center. All rights reserved.
